On Monday, Amneal Pharmaceuticals Inc (AMRX) stock saw a modest uptick, ending the day at $8.32 which represents a slight increase of $0.13 or 1.59% from the prior close of $8.19. The stock opened at ...

Amneal Pharmaceuticals (AMRX) and Metsera have entered into a collaboration agreement to enable the efficient development and ...

Amneal Pharmaceuticals Inc (AMRX) stock saw a decline, ending the day at $8.52 which represents a decrease of $-0.18 or -2.07% from the prior close of $8.7. The stock opened at $8.67 and touched a low ...

Amneal Pharmaceuticals has sued Colorado in an effort to block a state law requiring it to provide free generic EpiPens to ...

View Amneal Pharmaceuticals, Inc. (AMRX) current and estimated P/E ratio data provided by Seeking Alpha.

INDICATION CREXONT (carbidopa and levodopa) extended-release capsules is a prescription medication for the treatment of Parkinson’s disease, Parkinson’s disease caused by infection or inflammation of ...

BRIDGEWATER, N.J., September 05, 2024--Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX) ("Amneal" or the "Company") and Shilpa Medicare Limited ("Shilpa") announced U.S ...

Detailed price information for Amneal Pharmaceuticals Inc (AMRX-Q) from The Globe and Mail including charting and trades.

27 – Oct. 1, 2024 Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX) (“Amneal” or the “Company”) today announced that it has launched CREXONT® (carbidopa ...

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Amneal Pharmaceuticals (AMRX – Research Report), Aura Biosciences Inc (AURA – Research Report) and Terns ...

Bausch Health is rumored to be looking to sell its Bausch + Lomb business, which will ease bankruptcy concerns and upgrade ...